{"id":531483,"date":"2021-02-24T06:36:01","date_gmt":"2021-02-24T06:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=531483"},"modified":"2021-02-24T06:36:01","modified_gmt":"2021-02-24T06:36:01","slug":"metastatic-colorectal-cancer-mcrc-market-size-share-epidemiology-and-competitive-analysis-report-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/metastatic-colorectal-cancer-mcrc-market-size-share-epidemiology-and-competitive-analysis-report-2030_531483.html","title":{"rendered":"Metastatic Colorectal Cancer (mCRC) Market Size, Share, Epidemiology and Competitive Analysis Report 2030"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1614056905.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Metastatic Colorectal Cancer (mCRC) Market Size, Share, Epidemiology and Competitive Analysis Report 2030\" src=\"https:\/\/www.abnewswire.com\/uploads\/1614056905.jpeg\" alt=\"Metastatic Colorectal Cancer (mCRC) Market Size, Share, Epidemiology and Competitive Analysis Report 2030\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u2018Metastatic Colorectal Cancer (mCRC) Market Insights, Epidemiology and Market Forecast\u2013 2030\u2019 report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\">DelveInsight launched a new report on <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/metastatic-colorectal-cancer-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Metastatic Colorectal Cancer Market Insights, Epidemiology and Market Forecast 2030<\/strong><\/a>.<\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\">DelveInsight&rsquo;s &lsquo;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/metastatic-colorectal-cancer-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Metastatic Colorectal Cancer (mCRC) Market Report 2030<\/strong><\/a>&rsquo;&nbsp;report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/951c0d5ece9834c2c75e0daf23d9acbf.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\"><strong>About the Disease:<\/strong><\/p>\n<p style=\"text-align: justify;\">Colorectal cancer (CRC) is the third most common, with metastasis being the major cause of death in the majority of patients. CRC starts in the colon or the rectum. These cancers can also be called colon cancer or rectal cancer, depending on where they start. Colon cancer and rectal cancer are often grouped together because they have many features in common. CRC may develop when polyps, mushroom-like growths inside the colon, grow and become cancerous or cells along the lining of the colon or rectum mutate and grow out of control, forming a tumor.<\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><strong>Metastatic Colorectal Cancer Treatment Therapies:<\/strong><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><span data-mce-mark=\"1\">1. Radiation therapy<\/span><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><span data-mce-mark=\"1\">2. Immunotherapy<\/span><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><span data-mce-mark=\"1\">3. Chemotherapy<\/span><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><strong><span>Request for a detailed sample copy of the report:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/metastatic-colorectal-cancer-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><span data-sheets-value=\"{\" data-sheets-userformat=\"{\">https:\/\/www.delveinsight.com\/sample-request\/metastatic-colorectal-cancer-market<\/span><\/a><\/span><\/strong><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><strong><span data-mce-mark=\"1\"><strong>Metastatic Colorectal Cancer&nbsp;<\/strong>Epidemiology insights:<\/span><\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li class=\"ql-align-justify\"><span data-mce-mark=\"1\">The incident population of&nbsp;<\/span>CRC&nbsp;<span data-mce-mark=\"1\">in the&nbsp;<\/span><span data-mce-mark=\"1\">seven major markets<\/span><span data-mce-mark=\"1\">&nbsp;was&nbsp;<\/span><span data-mce-mark=\"1\">518,742&nbsp;<\/span><span data-mce-mark=\"1\">in&nbsp;<\/span><span data-mce-mark=\"1\">2017.<\/span><\/li>\n<li class=\"ql-align-justify\"><span data-mce-mark=\"1\">The incident population of m<\/span>CRC&nbsp;<span data-mce-mark=\"1\">in the&nbsp;<\/span><span data-mce-mark=\"1\">seven major markets<\/span><span data-mce-mark=\"1\">&nbsp;is estimated to be&nbsp;<\/span><span data-mce-mark=\"1\">213,181&nbsp;<\/span><span data-mce-mark=\"1\">in&nbsp;<\/span><span data-mce-mark=\"1\">2020.<\/span><\/li>\n<li class=\"ql-align-justify\"><span data-mce-mark=\"1\">In the&nbsp;<\/span><span data-mce-mark=\"1\">United States<\/span><span data-mce-mark=\"1\">, the number<\/span><span data-mce-mark=\"1\">&nbsp;<\/span><span data-mce-mark=\"1\">of<\/span><span data-mce-mark=\"1\">&nbsp;males&nbsp;<\/span><span data-mce-mark=\"1\">and<\/span><span data-mce-mark=\"1\">&nbsp;females&nbsp;<\/span><span data-mce-mark=\"1\">with&nbsp;<\/span>CRC&nbsp;<span data-mce-mark=\"1\">is estimated to be&nbsp;<\/span><span data-mce-mark=\"1\">89,527&nbsp;<\/span><span data-mce-mark=\"1\">and<\/span><span data-mce-mark=\"1\">&nbsp;63,773<\/span><span data-mce-mark=\"1\">, respectively, in&nbsp;<\/span><span data-mce-mark=\"1\">2020<\/span><span data-mce-mark=\"1\">.<\/span><\/li>\n<\/ul>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><strong><strong>Metastatic Colorectal Cancer&nbsp;<\/strong>Therapy Assessment:<\/strong><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\">1. Braftovi (encorafenib) + Erbitux (cetuximab)\/ Braftovi + Mektovi: Array BioPharma\/ Pfizer<\/p>\n<p style=\"text-align: justify;\">2. Keytruda (pembrolizumab) injection: Merck<\/p>\n<p style=\"text-align: justify;\">3. Nivolumab (Opdivo) + Ipilimumab (Yervoy): Bristol-Myers Squibb<\/p>\n<p style=\"text-align: justify;\">4. Lonsurf: Taiho Oncology<\/p>\n<p style=\"text-align: justify;\"><strong><strong>Metastatic Colorectal Cancer&nbsp;<\/strong>Market Outlook<\/strong><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\">Colorectal cancer (CRC) is the second most frequent type of cancer that represents approximately 12&ndash;14% of all cancer cases in men and women. Out of these, approximately 25% of patients present with metastases at initial diagnosis and almost 50% may eventually develop metastases, contributing to the high mortality rates reported for CRC. In order to identify the optimal treatment strategy for patients with mCRC, tumor staging is essential and should include at least clinical examination, blood counts, liver and renal function tests, CEA, and CT scan of the abdomen and chest (or alternatively MRI).<\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\">The treatment plan may include a combination of surgery, radiation therapy, immunotherapy, and chemotherapy, which can be used to slow the spread of the disease and often temporarily shrink a cancerous tumor. Palliative care is also important to help relieve symptoms and side effects.<\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/metastatic-colorectal-cancer-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Click here and get more useful insights from our report.<\/strong><\/a><\/p>\n<p class=\"ql-align-justify\" style=\"text-align: justify;\"><strong>Key facts from our report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>The market size of mCRC in the&nbsp;<span data-mce-mark=\"1\">seven major markets<\/span>&nbsp;is estimated to be&nbsp;<span data-mce-mark=\"1\">USD 12,682 Million<\/span>&nbsp;in&nbsp;<span data-mce-mark=\"1\">2020.<\/span><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1 Key Insight<br \/> 2 Executive Summary of Metastatic Colorectal Cancer<br \/> 3 Metastatic Colorectal Cancer Market Overview at a Glance<br \/> 4 Disease Background and Overview: Metastatic Colorectal Cancer<br \/> 5 Case Reports<br \/> 6 Metastatic Colorectal Cancer Epidemiology and Patient Population<br \/> 7 United States Epidemiology<br \/> 8 EU5 Epidemiology<br \/> 9 Japan Epidemiology<br \/> 10 Current Metastatic Colorectal Cancer Treatment and Medical Practices<br \/> 11 Unmet needs<br \/> 12 Metastatic Colorectal Cancer Marketed Drugs<br \/> 13 Metastatic Colorectal Cancer Emerging Drugs<br \/> 14 Metastatic Colorectal Cancer 7MM Market Analysis<br \/> 15 United States<br \/> 16 EU-5 countries: Market Outlook<br \/> 17 Japan Market Outlook<br \/> 18 Metastatic Colorectal Cancer Market Drivers<br \/> 19 Metastatic Colorectal Cancer Market Barriers<br \/> 20 SWOT Analysis<br \/> 21 Reimbursement and market access<br \/> 22 Appendix<br \/> 23 DelveInsight Capabilities<br \/> 24 Disclaimer<br \/> 25 About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Download full report @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/metastatic-colorectal-cancer-market?utm_source=ABnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><span data-sheets-value=\"{\" data-sheets-userformat=\"{\">https:\/\/www.delveinsight.com\/report-store\/metastatic-colorectal-cancer-market<\/span><\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><br \/> DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=metastatic-colorectal-cancer-mcrc-market-size-share-epidemiology-and-competitive-analysis-report-2030\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=metastatic-colorectal-cancer-mcrc-market-size-share-epidemiology-and-competitive-analysis-report-2030\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight\u2019s \u2018Metastatic Colorectal Cancer (mCRC) Market Insights, Epidemiology and Market Forecast\u2013 2030\u2019 report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC market trends in the United States, EU5 &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/metastatic-colorectal-cancer-mcrc-market-size-share-epidemiology-and-competitive-analysis-report-2030_531483.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-531483","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=531483"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531483\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=531483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=531483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=531483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}